Join Dr. Nikesh Shah and Dr. D. Alan Kerr II from the Tampa General Hospital Cancer Institute as they explain the overview of CAR-T and bispecific antibodies in lymphoma, review toxicities of treatment and review challenges in access to care.

Accreditations

PHYSICIANS

ACCME
USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
USF Health designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Florida Board of Medicine
USF Health is an approved provider of continuing education for physicians through the Florida Board of Medicine. This activity has been reviewed and approved for up to 0.25 continuing education credits.

Target Audience: Hematologists, Oncologists, Primary Care Physicians
Release Date: 3/12/2024
Expiration Date: 3/12/2025

Relevant Financial Relationships
All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.
Nikesh Shah, MD: Malignant Hematologist, Tampa General Hospital Cancer Institute
Alan Kerr II, MD, PhD: Hematology & Medical Oncology, Tampa General Hospital Cancer Institute

Claim CME/CEU Credit for this episode here:
https://cmetracker.net/USF/Publisher?page=pubOpen#/getCertificate/358141/qr